NVG-hIL15
Nomenclature
NOD-PrkdcscidIl2rgem1Il15(hIL15)Smoc
Cat. NO.
GM-NVG-210001
Strain State
Repository Live
Model Description
Validation Data
Human IL15 expression analysis

Fig 1. Human IL15 expression analysis in homozygous NVG-hIL15 mice by ELISA.

Fig 2. Humanized immune reconstitution levels and body weight growth curves in huPBMC-NVG-hIL15 mice.

Fig 3. Humanized immune reconstitution levels in huPBNK-NVG-hIL15 mice.

Fig 4. Efficacy evaluation of CD20-targeting antibody using Raji huPBNK model.

Fig 5. Functional protein detection in NK cells in the presence of anti-hCD20 antibody drug using Raji huPBNK model.

Fig 6. ADCC efficacy research in vitro using huPBNK model.

Fig 7. Body weight growth curves in γδT-NVG-hIL15 mice.

Fig 8. Survial rates in γδT-NVG-hIL15 mice.

Fig 9. Humanized immune reconstitution levels in γδT-NVG-hIL15 mice.

Fig 10. Humanized immune reconstitution levels in huHSC-NVG-hIL15 mice. A. hCD45+ cell and mCD45+ cell in PB. B. hCD3+, hCD19+, hCD56+, hCD33+, hCD33+hCD14+, hCD33+ hCD66b+ cell in hCD45+ cell.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more